The CTAG1B gene, also known as NY-ESO-1, was found to be expressed in 6 out of 18 ChRCCs and 15 out of 17 ROs, suggesting its potential utility in diagnosing these tumours [58]. The gene discussed is CTAG1B; the disease is neoplasm.